StockWatch
·

Glenmark Life Sciences Ltd Q4 FY25 Results

ALIVUSQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue649.541.2%
Total Income659.631.1%
Expenditure468.340.3%
PBT191.293.3%
Net Profit141.873.6%
OPM30.55%5.77pp
NPM21.51%0.51pp
EPS11.573.5%
View full financials

Informational and educational content only. Not investment advice.